Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Completed 225 Unknown 65 Terminated 56 Recruiting 51 Active not recruiting 39 Not yet recruiting 17 Withdrawn 13 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 1

Interventions

Specimen Handling 8 Magnetic Resonance Spectroscopy 7 Biopsy 5 Nivolumab 4 Capecitabine 4 Vincristine 3 Radiosurgery 3 Paclitaxel 3 Irinotecan 3 Fluorouracil 3 Everolimus 3 Docetaxel 3 Dexamethasone 3 Cyclophosphamide 3 Cisplatin 3 Bevacizumab 3 trifluridine tipiracil drug combination 2 spartalizumab 2 pembrolizumab 2 lenvatinib 2 daratumumab 2 Taxes 2 Radiation 2 Prednisone 2 Pemetrexed 2 Oxaliplatin 2 Mitoxantrone 2 Leucovorin 2 Injections 2 Etoposide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Suspended × Trastuzumab × Clear all

NCT05062889 2026-02-03

ERASE-CRC

Gruppo Oncologico del Nord-Ovest

Phase 2 Suspended

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡